Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

836 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Emergence of SARS-CoV-2 with Dual-Drug Resistant Mutations During a Long-Term Infection in a Kidney Transplant Recipient.
Tanino Y, Nishioka K, Yamamoto C, Watanabe Y, Daidoji T, Kawamoto M, Uda S, Kirito S, Nakagawa Y, Kasamatsu Y, Kawahara Y, Sakai Y, Nobori S, Inaba T, Ota B, Fujita N, Hoshino A, Nukui Y, Nakaya T. Tanino Y, et al. Among authors: yamamoto c. Infect Drug Resist. 2024 Feb 8;17:531-541. doi: 10.2147/IDR.S438915. eCollection 2024. Infect Drug Resist. 2024. PMID: 38348230 Free PMC article.
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101).
Nishioka N, Imai H, Endo M, Notsu A, Doshita K, Igawa S, Yokouchi H, Ninomiya T, Tokito T, Soda S, Fujiwara T, Asao T, Nakamichi S, Kawamura T, Inomata M, Nakashima K, Ito K, Goto Y, Umeda Y, Hirai S, Ushio R, Yokoo K, Takeda T, Fukui T, Ishihara M, Osaki T, Kubo S, Fujiwara T, Yamamoto C, Tsuda T, Tamura N, Hosokawa S, Chihara Y, Ikeda S, Furuya N, Nakahara Y, Miura S, Okamoto H. Nishioka N, et al. Among authors: yamamoto c. Target Oncol. 2024 May;19(3):423-433. doi: 10.1007/s11523-024-01048-x. Epub 2024 Apr 13. Target Oncol. 2024. PMID: 38613731 Free PMC article.
Long-term management of moderate-to-severe atopic dermatitis with lebrikizumab and concomitant topical corticosteroids: a 68-week, randomized, double-blind, placebo-controlled phase III trial in Japan (ADhere-J).
Katoh N, Tanaka A, Takahashi H, Shimizu R, Kataoka Y, Torisu-Itakura H, Morisaki Y, Yamamoto C, Igawa K. Katoh N, et al. Among authors: yamamoto c. Br J Dermatol. 2024 Oct 23:ljae394. doi: 10.1093/bjd/ljae394. Online ahead of print. Br J Dermatol. 2024. PMID: 39442013
Features of causes of indirect certified disaster-related death in areas affected by the Fukushima Daiichi nuclear power plant accident: an observational study.
Uchi Y, Sawano T, Kawashima M, Nonaka S, Yoshimura H, Kitazawa K, Sakakibara M, Sudo M, Yagiuchi K, Otsuki M, Hori A, Ozaki A, Yamamoto C, Zhao T, Oikawa T, Niwa S, Tsubokura M. Uchi Y, et al. Among authors: yamamoto c. BMJ Open. 2024 Nov 19;14(11):e084009. doi: 10.1136/bmjopen-2024-084009. BMJ Open. 2024. PMID: 39566943 Free PMC article.
Medical Access and Care Continuity: Qualitative Assessments of Patients with Breast Cancer and Family Members' Experiences Following the 2011 Triple Disaster in Fukushima, Japan.
Singh P, Montesino S, Ozaki A, Murakami M, Kaneda Y, Abe T, Zhao T, Yamamoto C, Ito N, Amir I, Yamashita E, Saito H, Sawano T, Gonda K, Ohira H, Yanagisawa R, Katz C, Tsubokura M. Singh P, et al. Among authors: yamamoto c. Disaster Med Public Health Prep. 2024 Nov 11;18:e257. doi: 10.1017/dmp.2024.162. Disaster Med Public Health Prep. 2024. PMID: 39526410
836 results